• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Oral Systemic Treatment Options for a 28-Year-Old Woman With Moderate Atopic Dermatitis

The panelist discusses how a 28-year-old woman with moderate atopic dermatitis requires personalized, comprehensive management addressing hand involvement, corticosteroid concerns, and potential Janus kinase (JAK) inhibitor therapy, focusing on symptom relief, safety, and patient-specific factors.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is provided by the following:

      • Please provide your initial impressions of this case. Does the involvement of the patient’s hands influence your management plan at all?
      • How would you address the patient’s concerns regarding potential adverse effects of topical corticosteroids?
      • Describe your approach to treatment options for this patient. What patient-specific factors would you take into consideration when deciding on a treatment?
      • In what scenarios would a JAK inhibitor be preferred over another systemic agent?
      • How would decide between a topical or systemic JAK inhibitor for a patient?
      • What can the patient expect in terms of efficacy and safety with upadacitinib? When should she expect initial symptom relief?

      Newsletter

      Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

      © 2025 MJH Life Sciences

      All rights reserved.